Tufts Desacklerizes.

Time to tidy up the place.

Desacklerizing

Our period’s Decadent, Late.

Provenance: The Sackler Estate.

“But to pay for our Braques

With this family’s smahck

Is one step too far for the Tate.”

Desacklerizing: It Begins.

Now that you’ve addicted the poor and defenseless of America, you’re making aggressive plans to addict the poor and defenseless of China and India. The reward for that is cultural oblivion, which is exactly what you’re going to get.

Graduated Sackler; Has the Esformes Chair…

… how many more besmirched names can this guy fit on his business card?

‘Purdue Pharma is now taking Oxycontin into international markets with significantly less regulatory oversight. According to [one observer], “the Sackler family has only increased its efforts abroad, and is now pushing the drug, through a Purdue-related company called Mundipharma, into Asia, Latin America and the Middle East.”‘

When your school or museum starts considering whether to return Sackler money, keep this in mind. Not just depraved indifference. Fiercely determined depraved indifference.

Oh, and if Yale returns the Sackler money…!

Corey O’Hern, director of Undergraduate Programs for the Sackler Institute and a professor of mechanical engineering and materials science, emphasized the importance of the Institute in fostering collaboration between departments at Yale. According to O’Hern, there is a lack of grants supporting such research on the national level. “The funding, independent where it’s from, has been crucial to developing this interdisciplinary research and training,” said O’Hern. “The thought of it going away is scary, stressful and sad.”

Corey? Do you know what Yale’s currently hoarding in its endowment? Do you know that your university sits on thirty billion dollars? If you don’t realize that Yale doesn’t need Sackler money, I find that scary, stressful and sad. Just ask Andrew Kolodny:

Despite benefits from the Sackler Institute, Kolodny maintained that Yale has a moral impetus to rename the program. “Yale University, if they are taking money from the Sacklers, they are taking blood money,” Kolodny argued. “That money came from the marketing of the Sackler family’s activities which led to millions of people becoming addicted and thousands of people dying.”

“I think Yale University can afford to give the Sacklers back their money,” he added.

The Sacklers: A Clear Explanation.

For Andrew Kolodny, co-director of Opioid Policy Research at Brandeis University’s Heller School for Social Policy and Management, Purdue’s wrongdoing is the Sacklers’ wrongdoing. As the inventors and owners of Purdue, the Sacklers deserve the “lion’s share” of the blame for America’s opioid crisis, he said.

He explained that the United States’ opioid epidemic is as severe as it is because the medical community began aggressively to prescribe opioids in the ’90s in response to what Kolodny deems a “brilliant marketing campaign” carried out by Purdue. He said the company has faced legal consequences for some of the specific ways in which it marketed OxyContin, but it was never punished for the “nonbranded marketing” they performed by persuading the medical community to feel more comfortable prescribing opioids.

Sackler

For it is Sackler, Sackler, emblazoned on our faculty
But now it looks as though they got the dough through smack-dependency.

Yes it was Sackler, Sackler long before the o.d.s came.
But now the name has come to sound like scum — it’s a bad bad name.

Sackler Patriarch Responds to New York Times Article


Don’t tell me they’re too high — that’s simply not true.

If someone has to die, it’s them and not you.

Don’t bring around a cloud to rain on my charade!


‘Prescription blizzard deep and dense and so white’

This is the sort of poetry that I write.

This is the vast catastrophe that I have made!


[chorus]

More people killed by my little pill

Than traffic fatalities – right, sir!

More people thrilled by taking my pill

Before they all say goodnight, sir!


Med schools across the nation bear our great name

Philanthropy removes all sense of shame

As we distribute heroin — the highest grade!

In one end out the other

[A]s the country’s addiction crisis worsened, the Sacklers spied another business opportunity. They could increase their profits by selling treatments for the very problem their company had helped to create: addiction to opioids. ..

The business potential of adding addiction treatment to the mix was illustrated in internal company charts and diagrams.

“Pain treatment and addiction are naturally linked,” one Project Tango document, included in the New York complaint, said. It depicted a big blue funnel. The fat end was labeled “pain treatment”; the narrow end was labeled “opioid addiction treatment.”

The company, the document said, could make money at both ends of the funnel as an “end-to-end pain provider.”

************************

Sing it.

Smack and treatment smack and treatment
They go together in a way that’s sequent
This I tell you brother
You can’t have one without the other


Smack and treatment, smack and treatment
It’s a business plan we plan to frequent
Ask the local gentry
And they will say it’s elementary


Try, try, try to separate them
It’s an illusion
Try, try, try, and you will only come
To this conclusion

Smack and treatment smack and treatment

Have a flavor that Purdue finds piquant
Brother told to brother
You can’t have one you can´t have none
You can’t have one without the other


Try, try, try to separate them
It’s an illusion
Try, try, try, and you will only come
To this conclusion


Smack and treatment smack and treatment
They go together … well, enough repeatment
Brother told to brother
You can’t have one, you can´t have none
You can’t have one without the other
No sir

When the going gets tough, Tufts…

… just keeps going. That university doesn’t see why it should shut down its lucrative Sackler money-collection project just because everyone else is shutting theirs down. As UD predicted, it’s hemming and hawing and hemming and hawing. And the Tufts-Sackler love affair looks significantly ickier than that family’s other alliances, because, like the University of Toronto before it, Tufts seems to have let Sackler money mess with its curriculum.

The Sackler family also funded the Master of Science in Pain Research, Education & Policy (PREP) degree program within the Sackler school…

In a powerful editorial, the Tufts student newspaper says what needs to be said.

Companies identified human pain as a source of perpetual profit and knowingly created addictive and lethal substances to exploit that opportunity. This act was the ultimate perversion of medicine, a corruption of the relationship of trust and care that ought to exist between healthcare workers and the sick. Tufts took money from a company and a family whose fortune was based on knowingly creating addicts and lying about it. Tufts is still willing to take money from them.

Oklahoma!

OOOOOOklahoma!

Where the smack comes sweepin’ down the plain

Where the cowboys rope

Prescription dope

And it fucks so badly with your brain …

OOOOOOOklahoma! Every night my pharmacist and I

Sit alone and talk and watch a hawk

As we share the most amazing high…

We know we belong to the land

Of incessant controlled-sub demand

So when we say … Hey! The Sacklers just gave way!

We’re only saying you’re in a fix Oklahoma

Oklahoma nokay.

Guggenheim…

… calls time.

Samantha Bee discusses…

… the Sackler family.

My Sackler posts.

“When I use a word,” Humpty Dumpty said, in rather a scornful tone, “it means just what I choose it to mean—neither more nor less.”

In 1997, Richard [Sackler] was involved in discussion with employees of a Sackler-owned company in Germany over whether they could get regulatory authorities there to let them sell OxyContin as an uncontrolled drug. Though OxyContin developer Robert Kaiko warned that this was a terrible idea, Richard seemed supportive of the idea, asking in a subsequent message: “How substantially would it improve your sales?” But in his deposition, Richard insisted he was never a fan of the idea, arguing, “we were not in favor of this, but we were trying to be polite and solicitous rather than saying, this is a terrible idea, forget it, don’t do it.”

When the idea ultimately failed, Richard sent a message to an employee in Germany saying, “When we are next together we should talk about how this idea was raised and why it failed to be realized. I thought that it was a good idea if it could be done.”

In the deposition, Richard explained this by saying, “That’s what [my response] said, but I didn’t mean it. I just wanted to be encouraging.”

Next Page »

Latest UD posts at IHE

Archives

Categories